Key result
ECMO achieves up to ~78% overall survival in myocarditis-induced cardiogenic shock.
Design
Editorial
Authors
Loading...
Level 5 evidence leaves open clinical relevance; higher-quality trials needed before any adoption.
Yan Wang (2016) conducted an editorial in Cardiac and respiratory failure. Extracorporeal Membrane Oxygenation (ECMO) was evaluated. Extracorporeal membrane oxygenation serves as a vital life-sustaining therapy in emergency medicine, with reports indicating overall survival between 55% and 78% for myocarditis-induced cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: